Acta Obstet Gynecol Scand

1. KEMPPAINEN M, Gissler M, Kirjavainen T
   Maternal asthma during pregnancy and the likelihood of neurodevelopmental disorders in offspring.
   Acta Obstet Gynecol Scand. 2024 Nov 14. doi: 10.1111/aogs.15008.
   

   >> Share

   
   
2. FRYKMAN J, Nilsson E, Wiberg-Itzel E, Wallstrom T, et al
   May the indication for a previous cesarean section affect the outcome at trial of labor in women with induction of labor? A retrospective cohort study.
   Acta Obstet Gynecol Scand. 2024 Nov 11. doi: 10.1111/aogs.15005.
   

   >> Share

   
   
3. TAUTENHAHN H, Dathan-Stumpf A, Kabbani N, Stepan H, et al
   The interplay of body mass index, gestational weight gain, and birthweight over 3800 g in vaginal breech birth: A retrospective study.
   Acta Obstet Gynecol Scand. 2024 Nov 9. doi: 10.1111/aogs.15002.
   

   >> Share

   
   
4. FERNANDEZ-LOPEZ R, Andreasen K, Ankerstjerne L, Martin-de-Las-Heras S, et al
   Prevalence and associated factors of intimate partner violence against pregnant women who attend antenatal care in Denmark and Spain: A digital screening approach.
   Acta Obstet Gynecol Scand. 2024 Nov 7. doi: 10.1111/aogs.15000.
   

   >> Share

   
   
5. JEPPEGAARD M, Frolich MK, Thomsen LCV, Heino A, et al
   Perinatal death in the Nordic countries in relation to gestational age: The impact of registration practice.
   Acta Obstet Gynecol Scand. 2024 Nov 5. doi: 10.1111/aogs.14950.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

6. HARPER LM, Szychowski JM, Tita ATN
   Addressing Limitations and Expanding Perspectives of Blood Pressure Control in Pregnancies Complicated by Diabetes.
   Am J Obstet Gynecol. 2024 Nov 7:S0002-9378(24)01123.
   

   >> Share

   
   
7. ROLNIK DL, Wright D, Nicolaides KH
   Aspirin Discontinuation in High-Risk Pre-eclampsia: The Role of Vascular Versus Placental Factors - Authors' reply.
   Am J Obstet Gynecol. 2024 Nov 7:S0002-9378(24)01115.
   

   >> Share

   
   
8. XU M, Yin X, Gong Y
   Association of premature natural and surgical menopause with incidence of depression requiring hospitalization: A prospective cohort study.
   Am J Obstet Gynecol. 2024 Nov 7:S0002-9378(24)01129.
   

   >> Share

   
   
9. SPARKS A, Kincaid H, Shivraj P, Young A, et al
   Understanding the Performance of Two Large Language Models in Obstetrics and Gynecology Maintenance of Certification.
   Am J Obstet Gynecol. 2024 Nov 7:S0002-9378(24)01117.
   

   >> Share

   
   
10. CHATZAKIS C, Charakida M, Nicolaides KH
    FIRST-TRIMESTER MATERNAL OPHTHALMIC ARTERY DOPPLER IS ASSOCIATED WITH INSULIN TREATED GESTATIONAL DIABETES MELLITUS.
    Am J Obstet Gynecol. 2024 Nov 7:S0002-9378(24)01113.
    

    >> Share

    
    
11. PATEL N, Callins K
    Reevaluation of the Tight Blood Pressure Control in Pregnant Patients.
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01122.
    

    >> Share

    
    
12. JASSET OJ, Lopez Zapana PA, Bahadir Z, Shook L, et al
    Enhanced placental antibody transfer efficiency with longer interval between maternal RSV vaccination and birth.
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01125.
    

    >> Share

    
    
13. KLEEBAYOON A, Wiwanitkit V
    Blood Pressure Control in Pregnant Patients with Chronic Hypertension and Diabetes: Comments.
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01120.
    

    >> Share

    
    
14. ROBISTOW L, Smith H, Vo C
    Vascular Resistance and Gestational Diabetes Mellitus: Correlation or Coincidence?
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01112.
    

    >> Share

    
    
15. KOTASKA A, Krause M, Beaudet L
    Low-lithotomy Cesarean Section for the Impacted Fetal Head.
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01110.
    

    >> Share

    
    
16. PATEL B, Callins KR
    Uterine Closure During Cesarean Delivery: "2Close Study".
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01118.
    

    >> Share

    
    
17. NOORAFROOZ M, Dashtkoohi M, Hantoushzadeh S
    Aspirin Discontinuation in High-Risk Pre-eclampsia: The Role of Vascular Versus Placental Factors.
    Am J Obstet Gynecol. 2024 Nov 6:S0002-9378(24)01114.
    

    >> Share

    
    
18. BURN MS, Kwah J, Son M
    Diagnosis and Clinical Management of Drug Allergies in Obstetrics and Gynecology: An Expert Review.
    Am J Obstet Gynecol. 2024 Oct 26:S0002-9378(24)01086.
    

    >> Share

    
    
19. PETERS SN, Fuller SM, Schmiedecke SS
    Laparoscopic endoloop excision of non-communicating rudimentary uterine horn ectopic pregnancy in the first trimester.
    Am J Obstet Gynecol. 2024 Oct 25:S0002-9378(24)01087.
    

    >> Share

    
    
20. BERGMAN L, Hannsberger D, Schell S, Imberg H, et al
    Cerebral infarcts, edema, hypoperfusion and vasospasm in preeclampsia and eclampsia.
    Am J Obstet Gynecol. 2024 Oct 30:S0002-9378(24)01106.
    

    >> Share

    
    

    
    Ann Oncol

21. HARTER P, Marth C, Mouret-Reynier MA, Cropet C, et al
    Efficacy of subsequent therapies in patients with advanced ovarian cancer who relapse after first-line olaparib maintenance: results of the PAOLA-1/ENGOT-ov25 trial.
    Ann Oncol. 2024 Nov 9:S0923-7534(24)04907-X. doi: 10.1016/j.annonc.2024.
    

    >> Share

    
    

    
    Aust N Z J Obstet Gynaecol

22. PITTMAN J, Gerstl B, Walch A, Lotz M, et al
    Psychological well-being of women with uterine infertility before considering uterus transplantation as a treatment option.
    Aust N Z J Obstet Gynaecol. 2024 Nov 12. doi: 10.1111/ajo.13895.
    

    >> Share

    
    
23. ABOUD L, Tanner H, Parsonage W, Lust K, et al
    Haemorrhagic and thromboembolic outcomes in pregnant patients with mechanical heart valves who undergo interruption of anticoagulation for birth - A case series.
    Aust N Z J Obstet Gynaecol. 2024 Nov 4. doi: 10.1111/ajo.13897.
    

    >> Share

    
    

    
    BMC Cancer

24. AKHAVAN S, Hoorshad N, Mousavi AS, Sheikhhasani S, et al
    The role of single-dose prophylactic methotrexate in the prevention of post-molar gestational trophoblastic neoplasia in patients with high-risk molar pregnancy.
    BMC Cancer. 2024;24:1400.
    

    >> Share

    
    
25. CHEN X, Jiang H, Xu H, Wang L, et al
    Cervical cancer screening: efficacy of PAX1 and JAM3 methylation assay in the triage of atypical squamous cell of undetermined significance (ASC-US).
    BMC Cancer. 2024;24:1385.
    

    >> Share

    
    
26. FU YP, Lin H, Ou YC, Wu CH, et al
    Bevacizumab as a mitigating factor for the impact of high systemic immune-inflammation index on chemorefractory in advanced epithelial ovarian cancer.
    BMC Cancer. 2024;24:1377.
    

    >> Share

    
    
27. MAURER T, Belau MH, Zyriax BC, Welsch G, et al
    Study protocol of an exercise and nutrition intervention for ovarian cancer patients during and after first-line chemotherapy (BENITA) - a randomized controlled trial.
    BMC Cancer. 2024;24:1379.
    

    >> Share

    
    
28. EFFAH K, Tekpor E, Wormenor CM, Allotey J, et al
    Cervical precancer screening using self-sampling, HPV DNA testing, and mobile colposcopy in a hard-to-reach community in Ghana: a pilot study.
    BMC Cancer. 2024;24:1367.
    

    >> Share

    
    
29. ITO H, Yokoyama Y, Kyo S, Mandai M, et al
    Interim analysis of robot-assisted radical hysterectomy in Japan: a multicenter, prospective interventional single-arm clinical trial.
    BMC Cancer. 2024;24:1360.
    

    >> Share

    
    
30. YANG S, Wang J, Du Z, Sheng C, et al
    An in vitro investigation into the cytotoxic impact of antigen-presenting dendritic cell-tumor infiltrating lymphocytes on ovarian cancer cells.
    BMC Cancer. 2024;24:1364.
    

    >> Share

    
    
31. CHEN H, Ma Y, Wang D, Wu H, et al
    The efficacy and safety of the prophylactic application of PEG-rhG-CSF in radiotherapy with weekly concurrent chemotherapy for cervical cancer.
    BMC Cancer. 2024;24:1405.
    

    >> Share

    
    
32. CHAO A, Huang CY, Yu W, Lin CY, et al
    Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinoma.
    BMC Cancer. 2024;24:1403.
    

    >> Share

    
    

    
    BMJ

33. IACOBUCCI G
    All women with suspected endometriosis should be offered ultrasound scans, says NICE.
    BMJ. 2024;387:q2502.
    

    >> Share

    
    
34. HOODA A
    Endometriosis: reasons for cautious optimism.
    BMJ. 2024;387:q2422.
    

    >> Share

    
    
35. SILBERNER J
    Abortion dominant, but health sidelined: the road to Trump's win.
    BMJ. 2024;387:q2456.
    

    >> Share

    
    
36. O'DOWD A
    NICE reiterates importance of HRT for menopausal symptoms.
    BMJ. 2024;387:q2460.
    

    >> Share

    
    
37. SACKEIM M
    Banning abortion prevents us from providing safe care to all pregnant women.
    BMJ. 2024;387:q2459.
    

    >> Share

    
    
38. ROEMER M
    We must safeguard access to both medical and surgical abortion methods.
    BMJ. 2024;387:q2413.
    

    >> Share

    
    

    
    Br J Radiol

39. ARIAN A, Karimi N, Ahmadinejad N, Azadnajafabad S, et al
    Refining MRI Protocols for Endometriosis: A Comparative Study of Abbreviated and Full MRI Sequences.
    Br J Radiol. 2024 Nov 12:tqae230. doi: 10.1093.
    

    >> Share

    
    

    
    Cancer Lett

40. FIELD NR, Dickson KA, Nassif NT, Marsh DJ, et al
    SMARCA4 and SMARCA2 co-deficiency: An uncommon molecular signature defining a subset of rare, aggressive and undifferentiated malignancies associated with defective chromatin remodeling.
    Cancer Lett. 2024;605:217282.
    

    >> Share

    
    

    
    Cancer Res

41. HAANEN TJ, Boock S, Callahan CG, Peris I, et al
    Mutant PP2A Induces IGFBP2 Secretion to Promote Development of High-Grade Uterine Cancer.
    Cancer Res. 2024 Nov 12. doi: 10.1158/0008-5472.CAN-24-1263.
    

    >> Share

    
    

    
    Eur J Cancer

42. MATIAS-GUIU X, Lax S, Raspollini MR, Palacios J, et al
    FIGO 2023 staging for endometrial cancer, when, if it is not now?
    Eur J Cancer. 2024;213:115115.
    

    >> Share

    
    

    
    Eur J Obstet Gynecol Reprod Biol

43. TSIAPAKIDOU S, Khattak H, Mukhopadhyay S, Mahmood T, et al
    Safer Sex. Access, availability, and quality of sexually transmitted infections healthcare across Europe: Call for Action by the European Board and College of Obstetrics & Gynaecology (EBCOG) and European Society of Contraception (ESCRH).
    Eur J Obstet Gynecol Reprod Biol. 2024;303:349-354.
    

    >> Share

    
    
44. GONCALVES OR, Bendaham LCAR, Simoni GH, Kojima GSA, et al
    Comparative efficacy and safety between intravenous labetalol and intravenous hydralazine for hypertensive disorders in pregnancy: A systematic review and meta-analysis of 19 randomized controlled trials.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:337-344.
    

    >> Share

    
    
45. MORRISON JC, Dempsey MA, Greaney C, Morrison JJ, et al
    Smoking during pregnancy in an Irish obstetric Population: Prevalence, maternal and ethnic factors.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:317-321.
    

    >> Share

    
    
46. SANTULLI P, Giraudet G, Estrade JP, Indersie E, et al
    Impact of endometriosis on partners: Results from the French EndoVie survey.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:310-316.
    

    >> Share

    
    
47. YIN X, He L, Xu H, Lou S, et al
    Efficacy and safety of different doses of mifepristone in the treatment of uterine fibroids: A meta-analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:302-309.
    

    >> Share

    
    
48. ROMAN MP, Ciortea R, Doumouchtsis SK, Din R, et al
    A quality assessment and systematic review of clinical practice guidelines on hormone replacement therapy for menopause using the AGREE II instrument.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:294-301.
    

    >> Share

    
    
49. PAUL-DEHLINGER R, Chatzistergiou K, Chanier JB, Bierry G, et al
    Impact of vaginism on mode of delivery and obstetrical outcomes.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:288-293.
    

    >> Share

    
    
50. SHARMA R, Dunn MC, Tam Tam H, Shah SK, et al
    CardioMEMS as an aid to the management of a pregnant patient with peripartum Cardiomyopathy: A case report.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:279-281.
    

    >> Share

    
    
51. MKHIZE PZ, Dorsamy V, Khaliq OP, Bagwandeen C, et al
    The effectiveness of low-dose aspirin for the prevention of hypertensive disorders of pregnancy in a sub-Saharan Africa Country: A randomized clinical trial.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:259-265.
    

    >> Share

    
    
52. SONAGLIONI A, Bruno A, Pusca I, Luigi Nicolosi G, et al
    The effect of previous history of Pre-Eclampsia on subclinical carotid atherosclerosis up to 20 years Postpartum: A systematic review and Meta-Analysis.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:250-258.
    

    >> Share

    
    
53. MAK KS, Huang YT, Hsuan Weng C, Wu KY, et al
    Factors affected the ovarian reserve after laparoscopic cystectomy for ovarian endometriomas.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:244-249.
    

    >> Share

    
    
54. MAUDOT C, Debras E, Laurent-Bellue A, Dupeux M, et al
    Caesarean section scar: Histological analysis on hysterectomy specimen. A pilot study.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:236-243.
    

    >> Share

    
    
55. NIETO-PASCUAL L, Lopez-Yarto M, Aguero Marino M, Martinez Garcia S, et al
    A multi-center study on the use of lidocaine thermogel for pain control in outpatient operative hysteroscopy.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:230-235.
    

    >> Share

    
    
56. AKBARI SENE A, Zandieh Z, Amiri S, Amjadi F, et al
    Evaluation of the effect of an amniotic membrane derived bio-nano product (LifeCell) on human endometrial cells proliferation and gene expression: An in-vitro study.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:224-229.
    

    >> Share

    
    
57. CERSONSKY TEK, Ayala NK, Tucker NS, Saade GR, et al
    Adherence to recommended prenatal visit schedules and risk for stillbirth, according to probable cause of death.
    Eur J Obstet Gynecol Reprod Biol. 2024;303:159-164.
    

    >> Share

    
    

    
    Fertil Steril

58. GIANNELLA L, Natalini L, Ciavattini A
    A misleading case of Mullerian anomaly: fibroid degeneration and growth involving nonfunctional, noncommunicating rudimentary horn.
    Fertil Steril. 2024;122:948-950.
    

    >> Share

    
    
59. KIRUBARAJAN A, Shea AK
    Response to: Enhancing Health Management in Patients with Primary Ovarian Insufficiency: An In-depth Exploration of Multimorbidity Associations.
    Fertil Steril. 2024 Nov 11:S0015-0282(24)02387.
    

    >> Share

    
    
60. TONER JP, Pirtea P
    Luteinizing Hormone (LH)'s critical role in ovarian stimulation (OS).
    Fertil Steril. 2024 Nov 8:S0015-0282(24)02383.
    

    >> Share

    
    
61. MARIA CHIARA A, Danilo B, Brunella Z, Alessandra G, et al
    Embryofetoscopy followed by hysteroscopic evacuation of a first-trimester missed abortion in a woman with septate uterus.
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02378.
    

    >> Share

    
    
62. BERNDT SL, Watanabe Ribeiro L, Rowlands I, Doust J, et al
    Childhood adversity and risk of endometriosis, fibroids, and polycystic ovary syndrome: A systematic review.
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02356.
    

    >> Share

    
    
63. PARPEX G, Belan M, Tazi A, Campin L, et al
    Characteristics and outcomes in endometrioma infections: a cohort of 94 cases.
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02379.
    

    >> Share

    
    
64. RYDZE RT, Gunderson SJ, Sandlow J
    Preeclampsia: More Than Just a Maternal Disease.
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02355.
    

    >> Share

    
    
65. HAYWOOD KG, Fox C
    Response to "A comparison of pregnancy outcomes and congenital malformations in offspring between patients undergoing intracytoplasmic sperm injection and conventional in vitro fertilization: a retrospective cohort study".
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02353.
    

    >> Share

    
    
66. OSUGA Y, Kobayashi T, Hirakawa A, Takayanagi T, et al
    Efficacy and safety of estetrol (E4) 15 mg/drospirenone (DRSP) 3 mg combination in a cyclic regimen for the treatment of primary and secondary dysmenorrhea: A multicenter, placebo-controlled, double-blind, randomized study.
    Fertil Steril. 2024 Nov 7:S0015-0282(24)02381.
    

    >> Share

    
    
67. MATEVOSSIAN K, Sauerbrun-Cutler MT, Konda S, Chen A, et al
    The Effects of BRCA1 and 2 Mutations on Ovarian Reserve and Aging.
    Fertil Steril. 2024 Nov 6:S0015-0282(24)02377.
    

    >> Share

    
    
68. ERDEN M, Oktay KH
    Pharmacological and Surgical Strategies to Improve Cryopreserved Ovarian Tissue Transplantation Longevity and Outcomes.
    Fertil Steril. 2024 Nov 5:S0015-0282(24)02376.
    

    >> Share

    
    
69. GAML-SORENSEN A, Brix N, Henriksen TB, Ramlau-Hansen CH, et al
    Author reply regarding: Maternal stress in pregnancy and pubertal timing in girls and boys: a cohort study.
    Fertil Steril. 2024 Oct 30:S0015-0282(24)02343.
    

    >> Share

    
    

    
    Gynecol Oncol

70. JAIN D, Zaeim F, Wahidi M, Smith WJ, et al
    Cervical squamous cell carcinoma outcomes across continents: A retrospective study.
    Gynecol Oncol. 2024;190:272-282.
    

    >> Share

    
    
71. PROPPE L, Jaeger A, Goy Y, Petersen C, et al
    Systematic review - Adjuvant radiotherapy of the vulva in primary vulvar cancer.
    Gynecol Oncol. 2024;190:264-271.
    

    >> Share

    
    
72. CHOI YK, Lee JH, Kim YS, Wee CW, et al
    Mid-treatment MRI-based tumor response assessment for tumor recurrence and patient survival in locally advanced adenocarcinoma of the cervix: A retrospective multicenter study of KROG 23-03.
    Gynecol Oncol. 2024;190:222-229.
    

    >> Share

    
    
73. SHIBATA M, Yoshida K, Yokoi A, Suzuki H, et al
    Elucidation of the role of XBP1 in the progression of complete hydatidiform mole to invasive mole through RNA-seq.
    Gynecol Oncol. 2024;190:189-199.
    

    >> Share

    
    
74. NONZEE NJ, Thiel de Bocanegra H, Navarro S, Bastani R, et al
    Impact of management guidelines for abnormal cervical cytology on colposcopy procedure rates among young women.
    Gynecol Oncol. 2024;190:160-166.
    

    >> Share

    
    
75. HEUS C, Stelten S, Kenter GG, Buffart LM, et al
    Body composition and peri- and postoperative complications in patients with gynaecological malignancies: A systematic review.
    Gynecol Oncol. 2024;190:131-138.
    

    >> Share

    
    
76. WEBBER JW, Wollborn L, Mishra S, Vitonis AF, et al
    Serum miRNA improves the accuracy of a multivariate index assay for triage of an adnexal mass.
    Gynecol Oncol. 2024;190:124-130.
    

    >> Share

    
    
77. METCALF CA, Page CE, Stocker BOS, Johnson RL, et al
    Treating new-onset cognitive complaints after risk-reducing salpingo-oophorectomy: A randomized controlled crossover trial of lisdexamfetamine.
    Gynecol Oncol. 2024;190:62-69.
    

    >> Share

    
    
78. MERTEN R, Strnad V, Karius A, Lotter M, et al
    Brachytherapy in vaginal cancer for organ preservation: Clinical outcome and safety from a single center experience.
    Gynecol Oncol. 2024;190:35-41.
    

    >> Share

    
    
79. TEE XR, Hazard E, Latorre-Esteves E, Kohrn BF, et al
    Increased TP53 somatic evolution in peritoneal washes of individuals with BRCA1 germline mutations.
    Gynecol Oncol. 2024;190:18-27.
    

    >> Share

    
    
80. MULUGETA-GORDON L, Smith AJB
    Insurance coverage and access to gynecologic oncology: Where are we are now.
    Gynecol Oncol. 2024;192:56-58.
    

    >> Share

    
    
81. FRANCIS KE, Simon S, Gebski V, Joly F, et al
    Adverse events in the placebo arm of SOLO2/ENGOT-Ov21 maintenance trial of olaparib in recurrent ovarian cancer.
    Gynecol Oncol. 2024;192:50-55.
    

    >> Share

    
    
82. POWELL MA, Cibula D, O'Malley DM, Boere I, et al
    Efficacy and safety of dostarlimab in combination with chemotherapy in patients with dMMR/MSI-H primary advanced or recurrent endometrial cancer in a phase 3, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY).
    Gynecol Oncol. 2024;192:40-49.
    

    >> Share

    
    
83. COLEMAN RL, Lubinga SJ, Shen Q, Walder L, et al
    Cost-effectiveness of dostarlimab plus carboplatin-paclitaxel for primary advanced or recurrent endometrial cancer from a US payer perspective.
    Gynecol Oncol. 2024;192:24-31.
    

    >> Share

    
    
84. BROWN J
    Hormonal maintenance therapy for advance low grade serous ovarian carcinoma appears to be of benefit - That's a relief!
    Gynecol Oncol. 2024;190:A1-A2.
    

    >> Share

    
    
85. DE JAEGHERE EA, Hamerlinck H, Tuyaerts S, Lippens L, et al
    Associations of the gut microbiome with outcomes in cervical and endometrial cancer patients treated with pembrolizumab: Insights from the phase II PRIMMO trial.
    Gynecol Oncol. 2024;191:275-286.
    

    >> Share

    
    
86. VREDE SW, Van Weelden WJ, Bulten J, Gilks CB, et al
    Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.
    Gynecol Oncol. 2024;192:15-23.
    

    >> Share

    
    
87. MOUFARRIJ S, Lakhman Y, Aghajanian C, Abu-Rustum NR, et al
    Evolutionary pathways in early-stage, non-myoinvasive endometrioid endometrial cancers of no specific molecular profile.
    Gynecol Oncol. 2024;192:8-14.
    

    >> Share

    
    
88. HICKEY M, Nguyen TL, Krejany EO, Domchek SM, et al
    What happens after menopause? (WHAM): Impact of risk-reducing salpingo-oophorectomy on depressive and anxiety symptoms at 24 months.
    Gynecol Oncol. 2024;192:1-7.
    

    >> Share

    
    
89. KILOWSKI KA, Dietrich MF, Xiu J, Baca Y, et al
    KRAS mutations in endometrial cancers: Possible prognostic and treatment implications.
    Gynecol Oncol. 2024;191:299-306.
    

    >> Share

    
    
90. KIM JH, Kim SI, Park EY, Ha HI, et al
    Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis.
    Gynecol Oncol. 2023;179:24-32.
    

    >> Share

    
    
91. LEE AW, Poynor V, Siddiqui S
    Disparities in ovarian cancer survival among ethnic Asian American populations, 2006-2020.
    Gynecol Oncol. 2024;191:292-298.
    

    >> Share

    
    
92. BOITANO TKL, Blank SV, Havrilesky LJ, Huh WK, et al
    Too much of a good thing? Projecting the need for gynecologic oncologists over the next 20 years.
    Gynecol Oncol. 2024;191:287-291.
    

    >> Share

    
    

    
    Hum Reprod

93. SHI L, Ying H, Dai Y, Rong Y, et al
    Upregulated let-7 expression in the follicular fluid of patients with endometriomas leads to dysfunction of granulosa cells through targeting of IGF1R.
    Hum Reprod. 2024 Nov 9:deae247. doi: 10.1093.
    

    >> Share

    
    
94. TANG X, Zhu Y, Cao Z, Wang X, et al
    CDC42 deficiency leads to endometrial stromal cell senescence in recurrent implantation failure.
    Hum Reprod. 2024 Nov 1:deae246. doi: 10.1093.
    

    >> Share

    
    

    
    Int J Cancer

95. JENSEN A, Guleria S, Albieri V, Nohr B, et al
    Fertility treatment and risk of ovarian cancer in a large nationwide cohort of infertile Danish women.
    Int J Cancer. 2024 Nov 14. doi: 10.1002/ijc.35251.
    

    >> Share

    
    
96. BONAVENTURE A, Simpson J, Kane E, Roman E, et al
    Maternal illnesses during pregnancy and the risk of childhood cancer: A medical-record based analysis (UKCCS).
    Int J Cancer. 2024 Nov 13. doi: 10.1002/ijc.35166.
    

    >> Share

    
    
97. WATLING CZ, Kelly RK, Watts EL, Graubard BI, et al
    Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women.
    Int J Cancer. 2024 Nov 5. doi: 10.1002/ijc.35244.
    

    >> Share

    
    
98. SCHAAFSMA M, Schuurman TN, Kootstra P, Issa D, et al
    Nationwide cohort study on the risk of high-grade cervical dysplasia and carcinoma after conservative treatment or hysterectomy for adenocarcinoma in situ.
    Int J Cancer. 2024 Nov 4. doi: 10.1002/ijc.35237.
    

    >> Share

    
    

    
    Int J Gynaecol Obstet

99. ROTEM R, Daniel G, O'Sullivan OE
    Letter to the editor: Clinician perspectives on hysterectomy versus uterine preservation in pelvic organ prolapse surgery: A systematic review and meta-analysis.
    Int J Gynaecol Obstet. 2024 Nov 14. doi: 10.1002/ijgo.16030.
    

    >> Share

    
    
100. HERAS M, Azcona L, Arencibia O, Minig L, et al
     Oncological safety of fertility preservation treatment in ovarian cancer: A Spanish multicenter study.
     Int J Gynaecol Obstet. 2024 Nov 14. doi: 10.1002/ijgo.16026.
     

     >> Share

     
     
101. LASMAR RB, Lasmar BP, Haimovich S, Pacheco LA, et al
     Proposal for a new classification of intrauterine adhesions by sites.
     Int J Gynaecol Obstet. 2024 Nov 13. doi: 10.1002/ijgo.16034.
     

     >> Share

     
     
102. MEHDIYEV S, Tanoglu FB, Altuncu ED, Oral E, et al
     Spontaneous hemoperitoneum in a 29-week pregnancy with a history of endometriosis: A case report and review of the literature.
     Int J Gynaecol Obstet. 2024 Nov 11. doi: 10.1002/ijgo.16006.
     

     >> Share

     
     
103. AHSAN F, Santoso B, Rahmawati NY, Alditia FN, et al
     Soluble adhesion molecules in serum and peritoneal fluid are associated with pelvic pain in endometriosis.
     Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16004.
     

     >> Share

     
     
104. WU T, Sun R, Sun J, Tao X, et al
     Circulating tumor HPV DNA as a specific biomarker for cervical cancer.
     Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16011.
     

     >> Share

     
     
105. CHENG TS, Zahir F, Solomi C 5th, Verma A, et al
     Does induction or augmentation of labor increase the risk of postpartum hemorrhage in pregnant women with anemia? A multicenter prospective cohort study in India.
     Int J Gynaecol Obstet. 2024 Nov 8. doi: 10.1002/ijgo.16008.
     

     >> Share

     
     
106. 
     Retraction: Comparison between the traditional non-guided and a novel ultrasound-guided technique for office fitting of intrauterine contraceptive devices.
     Int J Gynaecol Obstet. 2024 Nov 7. doi: 10.1002/ijgo.16003.
     

     >> Share

     
     
107. 
     Retraction: Five-year follow-up of two types of contraceptive device fitted during elective cesarean delivery.
     Int J Gynaecol Obstet. 2024 Nov 7. doi: 10.1002/ijgo.16002.
     

     >> Share

     
     
108. DAVE K, Desai S, Desai T, Desai G, et al
     Adverse maternal and fetal outcomes among tribal pregnant women suffering from sickle cell disease: A retrospective cohort study in a community-based hospital situated in a tribal block of Gujarat, India.
     Int J Gynaecol Obstet. 2024 Nov 6. doi: 10.1002/ijgo.15999.
     

     >> Share

     
     
109. FERREIRA AC, Dos Santos Guedes SM, Rodrigues TCGF, Barbosa PO, et al
     Proteinuria is associated with worse outcomes in babies born to mothers with preeclampsia: A retrospective cohort study at a tertiary referral hospital in Brazil.
     Int J Gynaecol Obstet. 2024 Nov 4. doi: 10.1002/ijgo.16007.
     

     >> Share

     
     
110. NIETO-CALVACHE AJ, Benavides-Calvache JP, Aryananda R, Palacios-Jaraquemada JM, et al
     Telemedicine ultrasound assessment for placenta accreta spectrum: Utility and interobserver reliability of asynchronous remote imaging review.
     Int J Gynaecol Obstet. 2024 Nov 2. doi: 10.1002/ijgo.15991.
     

     >> Share

     
     
111. ANTSAKLIS A, Capito LB, Pandit SN
     Ethics in the provision of obstetric and gynecologic health care for non-binary and transgender individuals.
     Int J Gynaecol Obstet. 2024 Nov 2. doi: 10.1002/ijgo.15925.
     

     >> Share

     
     
112. ENDLER M, Ramirez-Negrin A, Sohail R
     A silent pandemic of violence against providers in obstetrics and gynecology: A mixed-methods study based on a global survey.
     Int J Gynaecol Obstet. 2024 Nov 2. doi: 10.1002/ijgo.15985.
     

     >> Share

     
     
113. LOGSTEIN E, Torp R, Ashley T, Kamara MM, et al
     Long-term maternal outcomes 5 years after cesarean section in Sierra Leone: A prospective cohort study.
     Int J Gynaecol Obstet. 2024 Nov 2. doi: 10.1002/ijgo.15996.
     

     >> Share

     
     

     
     Int J Oncol

114. LIU Y, Xiao H, Zeng H, Xiang Y, et al
     Beyond tumor?associated macrophages involved in spheroid formation and dissemination: Novel insights for ovarian cancer therapy (Review).
     Int J Oncol. 2024;65:117.
     

     >> Share

     
     

     
     JAMA

115. PAN CQ, Dai E, Mo Z, Zhang H, et al
     Tenofovir and Hepatitis B Virus Transmission During Pregnancy: A Randomized Clinical Trial.
     JAMA. 2024 Nov 14. doi: 10.1001/jama.2024.22952.
     

     >> Share

     
     
116. TANG WZ, Liu TH, Lan X
     Selective vs Standard Obstetric Thromboprophylaxis Protocol.
     JAMA. 2024 Nov 13. doi: 10.1001/jama.2024.20498.
     

     >> Share

     
     
117. CHAMPION ML, Blanchard CT, Subramaniam A
     Selective vs Standard Obstetric Thromboprophylaxis Protocol-Reply.
     JAMA. 2024 Nov 13. doi: 10.1001/jama.2024.20504.
     

     >> Share

     
     
118. XIONG W
     Selective vs Standard Obstetric Thromboprophylaxis Protocol.
     JAMA. 2024 Nov 13. doi: 10.1001/jama.2024.20501.
     

     >> Share

     
     
119. ANDERER S
     Only About 5% of US Women Now Use Menopausal Hormone Therapy.
     JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22564.
     

     >> Share

     
     
120. ANDERER S
     Stool Metabolites Could Aid in Endometriosis Diagnosis and Therapy.
     JAMA. 2024 Nov 8. doi: 10.1001/jama.2024.22568.
     

     >> Share

     
     

     
     Lancet

121. 
     Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990-2021: findings from the Global Burden of Disease Study 2021.
     Lancet. 2024 Nov 4:S0140-6736(24)01925-1. doi: 10.1016/S0140-6736(24)01925.
     

     >> Share

     
     

     
     PLoS One

122. GAO S, Cui X
     Association between triglyceride glucose index and endometriosis in adults in the United States: A comprehensive study from the National Health and Nutrition Examination Survey (NHANES).
     PLoS One. 2024;19:e0313601.
     

     >> Share

     
     
123. BAWALLE AA, Nguyen TXT, Khan MSR, Kadoya Y, et al
     Impact of financial literacy and education on breast and cervical cancer screening participation in Japan.
     PLoS One. 2024;19:e0313687.
     

     >> Share

     
     
124. PLISKO O, Zodzika J, Jermakova I, Pcolkina K, et al
     Prediction of high-grade cervical precancerous abnormalities: The role of personal factors, vaginal microflora, sexually transmitted infections, and high-risk human papillomavirus.
     PLoS One. 2024;19:e0313004.
     

     >> Share

     
     
125. ILLIDGE S, Kort R, Hertzberger R
     'From women for women': A citizen science approach engaging women in the isolation and application of the vaginal health-associated bacterium Lactobacillus crispatus.
     PLoS One. 2024;19:e0308526.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share